+ All Categories
Home > Documents > N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204...

N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204...

Date post: 10-Jun-2020
Category:
Upload: others
View: 7 times
Download: 0 times
Share this document with a friend
40
Transcript
Page 1: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 2: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 3: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 4: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 5: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 6: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 7: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 8: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 9: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 10: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 11: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 12: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 13: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 14: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 15: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 16: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 17: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 18: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 19: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 20: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 21: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 22: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 23: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 24: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 25: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 26: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 27: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 28: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 29: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 30: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 31: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 32: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 33: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 34: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 35: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 36: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 37: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 38: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 39: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity
Page 40: N21-029 S005 Temozolomide Clinical BPCA › drugsatfda_docs › pediatric › 02102… · 204 pediatric patients with recurrent primary brain tumors and some non-CNS tumors The toxicity

Recommended